SCHEMBL21239550

SCHEMBL21239550

CC[C@@](C)(NC(=O)Nc1ccc(I)cc1)C(=O)O

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FPR2 P25090 6/20 0.57
▸ GAA P10253 2/20 0.44
▸ MAPT P10636 2/20 0.44
▸ THRB P10828 2/20 0.44
▸ RECQL P46063 2/20 0.44
▸ L3MBTL1 Q9Y468 2/20 0.44
▸ MEN1 O00255 2/20 0.44
▸ NPC1 O15118 2/20 0.44
▸ RAB9A P51151 2/20 0.44
▸ KMT2A Q03164 2/20 0.44
▸ CA12 O43570 2/20 0.42
▸ CA1 P00915 2/20 0.42
▸ CA2 P00918 2/20 0.42
▸ CA9 Q16790 2/20 0.42
▸ CNR1 P21554 1/20 0.41
▸ EPHX2 P34913 2/20 0.41
▸ KDM4E B2RXH2 1/20 0.41
▸ TP53 P04637 1/20 0.41
▸ PLEC Q15149 1/20 0.41
▸ ABCC9 O60706 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21239527 1.00 FPR2 (0.57) FPR2GAAMAPTTHRBRECQL
SCHEMBL21239525 1.00 FPR2 (0.57) FPR2GAAMAPTTHRBRECQL
SCHEMBL21239461 0.85 FPR2 (0.77) FPR2MEN1NPC1RAB9AKMT2A
SCHEMBL21239484 0.85 FPR2 (0.57) FPR2GAAMAPTMEN1NPC1
SCHEMBL21239464 0.85 FPR2 (0.57) FPR2GAAMAPTMEN1NPC1
SCHEMBL21239460 0.85 FPR2 (0.77) FPR2MEN1NPC1RAB9AKMT2A
SCHEMBL21239537 0.85 FPR2 (0.77) FPR2MEN1NPC1RAB9AKMT2A
SCHEMBL21239463 0.85 FPR2 (0.57) FPR2GAAMAPTMEN1NPC1
SCHEMBL21239468 0.80 FPR2 (0.52) FPR2GAAMAPTTHRBRECQL
SCHEMBL21239469 0.80 FPR2 (0.52) FPR2GAAMAPTTHRBRECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210206716-A1 UREA DERIVATIVE DAIICHI SANKYO COMPANY, LIMITED (JP) 2021-07-08 — — US claimed
EP-3524240-A1 UREA DERIVATIVE DAIICHI SANKYO COMPANY, LIMITED (JP) 2019-08-14 — — EP claimed
CN-109843283-A Urea derivative 第一三共株式会社 2019-06-04 — — CN claimed
CN-109843283-B Urea derivatives 第一三共株式会社 2022-08-30 — — CN disclosed
US-20220144765-A1 UREA DERIVATIVE DAIICHI SANKYO COMPANY, LIMITED (JP) 2022-05-12 — — US disclosed
US-20220144765-A1 UREA DERIVATIVE DAIICHI SANKYO COMPANY, LIMITED (JP) 2022-05-12 — — US disclosed
US-20210206716-A1 UREA DERIVATIVE DAIICHI SANKYO COMPANY, LIMITED (JP) 2021-07-08 — — US disclosed
US-20210206716-A1 UREA DERIVATIVE DAIICHI SANKYO COMPANY, LIMITED (JP) 2021-07-08 — — US disclosed
US-10968169-B2 Urea derivative DAIICHI SANKYO COMPANY, LIMITED (JP) 2021-04-06 — — US disclosed
US-10968169-B2 Urea derivative DAIICHI SANKYO COMPANY, LIMITED (JP) 2021-04-06 — — US disclosed
EP-3524240-A1 UREA DERIVATIVE DAIICHI SANKYO COMPANY, LIMITED (JP) 2019-08-14 — — EP disclosed
CN-109843283-A Urea derivative 第一三共株式会社 2019-06-04 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210206716-A1 UREA DERIVATIVE IDO1, IDO2, TPH1 FPR2 1882/4885GAA 1221/4885MAPT 1133/4885
US-10968169-B2 Urea derivative IDO1, IDO2, UTS2R FPR2 2003/4885GAA 1220/4885MAPT 1010/4885
US-20220144765-A1 UREA DERIVATIVE IDO1, IDO2, TPH1 FPR2 1882/4885GAA 1221/4885MAPT 1133/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback